Terren peizer dating
Catasys expressly disclaims any intent or obligation to update the forward-looking statements.
During this call we may also present certain non-GAAP financial measures and certain ratios that are used with these measures.
On January 20, 2017, the SDNY Court granted such motions by the Company to sever the Crede lawsuit into two separate cases.
Peizer is Chairman at Xcorporeal Operations, Inc., Chairman & Chief Executive Officer at Catasys, Inc., Chief Executive Officer at Intellect Capital Ventures LLC, and Chairman at Crede Captial Group, formerly Socius Capital Group LLC. Peizer served as President and Vice Chairman of Hollis-Eden Pharmaceuticals.
In October 2014, Peizer and 22nd Century formed a JV to commercialize the company’s products in China with China National Tobacco Company, the largest tobacco company in the world and the largest monopoly in China.
China represents over 50% of the worldwide tobacco market.
He served as a senior member of the investment banking firm of Drexel Burnham Lambert, Inc.'s High Yield Bond Department. Peizer held investment banking positions from 1981 to 1985 at Goldman, Sachs & Co.'s Risk and International Arbitrage Division as well as the First Boston Corp.'s High Yield Securities Department. Peizer received his BSE in Finance from the University of Pennsylvania-Wharton School of Finance and Commerce.
is currently the Chairman of his personal Los Angeles-based investment company, Acuitas Group Holdings (AGH), which in turn owns 100% of Crede Capital Group (CCG) which invests in public companies, and provides growth capital to small and medium-sized enterprises.